BioNTech plans to align and consolidate its manufacturing network further where excess capacity is expected, exploring divestment options for each site, including partial or total sales.
Kambi's Q1 2026 report shows a revenue of 43.5 million and an operating profit of 4.2 million, with EBITDA increasing significantly year-on-year. CEO Werner Becher stated that the quarter reflects a return to growth after a challenging 2025, characterized by major customer migrations.
Fatih Birol, head of the International Energy Agency, described the war in Iran as the biggest energy crisis in history, pointing to major disruptions in commodities, including fuel shortages and rising prices for consumers.
Cleveland-Cliffs reported a Q1 FY2026 adjusted loss of $0.40 per share, which beat the Street's estimate of a loss of $0.416 per share. The progress is real, but it's still a loss, and investors appear unwilling to reward the stock for simply losing less money.
GameStop ended Q4 with $9.01 billion in total cash, equivalents, and marketable securities, nearly double the $4.77 billion held a year prior. That buildup was funded by $4.2 billion in zero-coupon convertible notes issued during fiscal 2025.
Sonoco Products ( NYSE: SON) shares reached a 52-week high of $57.83 this week after strong 2025 results and 2026 guidance. That marks a 30% year-to-date surge that has far outpaced the S&P 500's fractional gain. The packaging company's rally accelerated following the February 17 earnings. With the stock at 52-week highs and technical indicators flashing warning signs, investors face the critical question of whether this momentum is sustainable or the valuation catch-up has run its course.
Medtronic ( NYSE: MDT) delivered its strongest enterprise revenue growth in 10 quarters, posting 8.7% reported growth (6.0% organic) for Q3 fiscal 2026. Cardiac Ablation Drives Outperformance The Cardiovascular Portfolio led the quarter with 13.8% reported growth, powered by an exceptional 80% surge in Cardiac Ablation Solutions. U.S. cardiac ablation revenue exploded 137%, driven by the company's pulsed field ablation (PFA) portfolio. Cardiac Rhythm & Heart Failure revenue reached $1.86 billion, up 17%, while Diabetes posted 8.3% organic growth to $796 million.
Carvana ( NYSE: CVNA) is down 15.1% over the past week, extending a brutal month that has seen shares fall 25.2% since mid-January. Yet Wall Street analysts still see the online used car retailer climbing to an average target of $481.05, implying 40.3% upside from current levels. That gap between price and target is now one of the widest among major consumer stocks,
InterContinental Hotels Group, owner of Holiday Inn, Crowne Plaza, and Hotel Indigo, reported robust revenue and profit growth for 2025, driven by a record hotel rollout and strategic acquisitions. The group opened 443 new hotels over the past year - adding more than 65,000 rooms - and completed its acquisition of the European hotel brand Ruby. Financially, IHG posted total revenue of $5.19 billion (£3.8 billion), up 5% from 2024, while operating profits rose 15% to $1.2 billion (£880 million).
In the last 12 months, the business delivered site EBITDA of £23m and EBITDA after central costs of £17m, cementing its position as the capital's leading independent pub operator. This is an increase of £5m versus reported EBITDA of £12.3m for the financial year ended 27 April 2025 - an uplift of almost 50%. The Group, which operates 66 high-quality sites across London, delivered its strongest-ever Christmas 2025 trading performance, capping an exceptional 2025.
Palantir celebrated its latest financial results on Monday, as the tech company blew past Wall Street expectations and continues to prop up the Trump administration's push to deport immigrants. Palantir has secured millions of dollars in federal contracts amid Trump's crackdown on immigrants. The multibillion-dollar Denver-based firm creates tech focused on surveillance and analytics, to be used by the government agencies and private companies.